Identification of specific proteins for glioma-initiating cells

B. Schatlo, M. Tenan, D. Marino, K. Schaller, I. Radovanovic & V.C. Clément-Schatlo
Objective: Malignant gliomas remain one of the most aggressive diseases with a 2-year survival rate of 32% with today's available standard treatments. A number of biomarkers such as GFAP, YKL-40 and S100b can be found in the blood of a proportion of glioma patients. However, it is unknown [for full text, please go to the a.m. URL]